What does Novartis' eye business envision without Alcon? Digital M&A, for one thing
admin 9th April 2019 Uncategorised 0Now that Alcon is officially off on its own, what is Novartis and its remaining eye medicine business looking at next? Cutting-edge innovations, including gene therapies and digital therapeutics, the franchise’s top executive said in an interview—and maybe some dealmaking, too.
More: What does Novartis' eye business envision without Alcon? Digital M&A, for one thing
Source: fierce